Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc. is a synthetic biology company founded in 2008 by MIT scientists. The company specializes in genetic engineering to design and program microorganisms for various industrial applications, including agriculture, food, healthcare, energy, chemicals, cosmetics, and biosecurity. Ginkgo aims to make biology programmable, treating organisms as manufacturing platforms through DNA code insertion into microbes like bacteria and yeast. The company offers organism engineering services, which include designing, testing, and licensing custom microbes. Ginkgo's innovative approach allows for the creation of tailored strains for specific functions, supported by autonomous labs and biological foundries. Their work spans multiple sectors, providing solutions for crop optimization, ingredient production, therapeutics, and more. Ginkgo has established partnerships with around 20 companies, focusing on licensing engineered organisms rather than producing end-products directly.